Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral atorvastatin for radiation-related complications in breast cancer radiotherapy
IRCT20181005041239N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Atorvastatin + radiotherapy with Placebo + radiotherapy (2 arms). Primary endpoints: Skin dermatitis evaluation and Quality of life assessment. Started Feb 2019; status: completed.
02
Drugs
atorvastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20181005041239N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181005041239N1.